I trust that you have had a restful festive period. It is with regret to announce that we are postponing the BSPGHAN Annual Meeting that was due to take place 26th -28th January 2022.
The priority is to keep our members and guests well and so we will need to limit social gathering, especially as we are experiencing unprecedented sick leave in our hospitals.
We worked hard to offer a virtual meeting in April 2021 and thank you for supporting that. Since the pandemic started, BSPGHAN has ensured that trainees, associates and members continue their professional development, offering superb online learning and training. A huge thanks to our energetic webmaster, Kwang Yang Lee, trainee supporters and members who have contributed to such a high quality educational series.
So why meet face to face in 2022?
The pandemic has highlighted the crucial importance of colleagues acting together – in particular, the challenges that span units, regions and nations. It has also reminded us the importance of working collaboratively and creatively to rethink priorities and shape future care.
The new date of 25th - 27th April 2022 will, we hope, will offer the chance to get together with confidence. We will provide as much notice as possible so that leave can be booked. Apologies for the inconvenience this has caused to our speakers, chairs, sponsors and those who have submitted abstracts and delegates who have registered – we will honour your registrations.
Please contact Carla, our administrator if you have queries or require a refund.
Stay well and safe. We anticipate advising you of the new dates within a few weeks.
With best wishes to you and your families and friends for a happy, peaceful and healthy New Year and the same throughout 2022.
I would like to personally thank the PGHAN Audit Steering Group, co chaired by John Fell and Ed Gaynor, Calvin Down from the RCPCH and all colleagues across the UK who have put time and effort into collecting and submitting information for the audit. This work continued to completion during the incredibly challenging circumstances of the COVID-19 pandemic.
This report, published jointly by The British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) and the RCPCH, highlights the main findings and recommendations identified through an audit of the provision of paediatric gastroenterology, hepatology and nutrition services for infants, children and young people with a wide range of conditions across the UK. Its recommendations offer healthcare professionals and providers expert guidance to drive improvement where needed.
The News page is here :https://www.rcpch.ac.uk/news-events/news/paediatricians-launch-landmark-report-gastrointestinal-liver-nutritional-disorders
Download your copy of The PGHAN/Audit report
Download Summaryof the PGHAN/ Audit report
Also see tweets https://twitter.com/RCPCHtweets/status/1471489611054551041
BSPGHAN President 2019 - 2022
In response to popular demand, the BSPGHAN 2022 organising committee is pleased to announce that the deadline for submission of abstracts has been extended to 26th November 2021 (end of 26 November).
Please go to https://conference.bspghan.org.uk to submit your abstract!
Please see updated Guidance from the JCVI
in addition to previous advice
At this time,
- the Pfizer-BioNTech BNT162b2 vaccine is the only vaccine authorised for persons aged 12 to 17 years in the UK
- JCVI advises that all 16 to 17-year-olds should be offered a first dose of Pfizer-BNT162b2 vaccine.
- Persons aged 12 to 15 years with specific underlying health conditions that put them at risk of severe COVID-19, should be offered 2 doses of Pfizer-BNT162b2 vaccine with an interval of 8 weeks between doses.
This currently includes children with severe neuro-disabilities, Down’s Syndrome, underlying conditions resulting in immunosuppression, profound and multiple learning disabilities (PMLD), severe learning disabilities or who are on the learning disability register. Details regarding additional person-groups with underlying health conditions to be offered vaccination will be provided as updates in the Green Book.
Children and young people aged 12 years and over who are household contacts of persons (adults or children) who are immunosuppressed should be offered 2 doses of Pfizer-BNT162b2 vaccine.
The rollout of Covid vaccination in England will be led through primary care. The letter notes: “We recognise that not all eligible 12-15 year olds may be identified through the GP record. Therefore, any approach by parents of children at increased risk should be considered and clinical judgement used around eligibility in line with JCVI advice. In addition, trusts may refer 12-15 year olds for a COVID-19 vaccination if they consider them to be eligible”
Letter to primary care -
FAQs on Vaccination delivery operations
Dr S Protheroe